Market News

Venbio Select Advisor Cut Its Veracyte (VCYT) Position by $3.16 Million; Stock Rose; Next Century Growth Investors Increased Its Stake in Insulet (PODD) as Shares Rose

Veracyte, Inc. (NASDAQ:VCYT) Logo

Venbio Select Advisor Llc decreased its stake in Veracyte Inc (VCYT) by 84.09% based on its latest 2018Q1 regulatory filing with the SEC. Venbio Select Advisor Llc sold 632,775 shares as the company’s stock rose 25.84% while stock markets declined. The institutional investor held 119,680 shares of the health care company at the end of 2018Q1, valued at $665,000, down from 752,455 at the end of the previous reported quarter. Venbio Select Advisor Llc who had been investing in Veracyte Inc for a number of months, seems to be less bullish one the $282.67M market cap company. The stock increased 3.52% or $0.28 during the last trading session, reaching $8.23. About 51,793 shares traded. Veracyte, Inc. (NASDAQ:VCYT) has declined 6.02% since June 13, 2017 and is downtrending. It has underperformed by 18.59% the S&P500. Some Historical VCYT News: 10/05/2018 – Veracyte to Launch New Afirma Xpression Atlas and Present Platform Performance Data at AACE 2018 Meeting; 11/04/2018 – VERACYTE: LOXO TO USE ITS AFIRMA XPRESSION ATLAS PLATFORM; 23/05/2018 – Veracyte: New Study Shows Afirma GSC’s Ability to Significantly Reduce Unnecessary Surgeries in Thyroid Cancer; 19/03/2018 – Veracyte Announces New Data Suggesting Afirma GSC’s Ability to Help Significantly More Patients Avoid Unnecessary Thyroid; 11/04/2018 – VERACYTE REPORTS PRECISION MEDICINE PACT WITH LOXO ONCOLOGY; 19/05/2018 – Veracyte Announces That Data From Multiple Studies Demonstrate “Real-World” Value of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis; 23/05/2018 – VCYT: AFIRMA GSC IDENTIFY ONE THIRD MORE BENIGN THYROID NODULES; 01/05/2018 – Veracyte 1Q Loss/Shr 27c; 16/05/2018 – Veracyte Announces Launch of New Afirma Xpression Atlas at 2018 AACE Congress; 11/04/2018 – Veracyte Announces Precision Medicine Collaboration With Loxo Oncology

Next Century Growth Investors Llc increased its stake in Insulet Corp (PODD) by 70.7% based on its latest 2018Q1 regulatory filing with the SEC. Next Century Growth Investors Llc bought 62,255 shares as the company’s stock rose 20.87% while stock markets declined. The institutional investor held 150,309 shares of the medical and dental instruments company at the end of 2018Q1, valued at $13.03 million, up from 88,054 at the end of the previous reported quarter. Next Century Growth Investors Llc who had been investing in Insulet Corp for a number of months, seems to be bullish on the $5.92B market cap company. The stock increased 0.79% or $0.79 during the last trading session, reaching $100.75. About 266,448 shares traded. Insulet Corporation (NASDAQ:PODD) has risen 117.40% since June 13, 2017 and is uptrending. It has outperformed by 104.83% the S&P500. Some Historical PODD News: 14/03/2018 lnsulet to Share Omnipod Clinical Data at Three Major European National Diabetes Congresses; 03/05/2018 – INSULET CORP PODD.O – FOR THE QUARTER ENDING JUNE 30, 2018, THE COMPANY IS INTRODUCING REVENUE GUIDANCE IN THE RANGE OF $130 TO $134 MILLION; 29/05/2018 – Insulet Presenting at Conference Jun 12; 22/04/2018 – DJ Insulet Corporation, Inst Holders, 1Q 2018 (PODD); 03/05/2018 – INSULET 1Q LOSS/SHR 11C, EST. LOSS/SHR 19C; 31/05/2018 – Factors of Influence in 2018, Key Indicators and Opportunity within Insulet, Everi, Ciner Resources LP, Aluminum Corporation of; 03/05/2018 – lnsulet Reports First Quarter 2018 Revenue of $123.6 Million, Up 21% Year-Over-Year, and Gross Margin of 61.4%, Up 300 Basis Points, Exceeding Expectations; 25/04/2018 – Hartford Growth Opportunities HLS Adds Insulet; 01/05/2018 – Insulet Establishes Two Significant Commercial Partnerships to Support its European Expansion; 25/04/2018 – Hartford Growth Opportunities Adds Insulet, Exits Booking

Among 6 analysts covering Veracyte (NASDAQ:VCYT), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Veracyte had 12 analyst reports since August 14, 2015 according to SRatingsIntel. The stock has “Overweight” rating by Piper Jaffray on Friday, August 14. The rating was upgraded by Janney Capital to “Buy” on Tuesday, November 29. Leerink Swann maintained the shares of VCYT in report on Tuesday, November 7 with “Outperform” rating. As per Friday, December 18, the company rating was initiated by Cantor Fitzgerald. Piper Jaffray maintained the stock with “Hold” rating in Wednesday, April 18 report. Piper Jaffray downgraded the stock to “Hold” rating in Tuesday, November 7 report. The rating was downgraded by Janney Capital to “Neutral” on Tuesday, November 7. The firm has “Buy” rating given on Friday, August 14 by BTIG Research.

More news for Veracyte, Inc. (NASDAQ:VCYT) were recently published by: Streetinsider.com, which released: “Veracyte (VCYT) Says New Study Published in JAMA Surgery Demonstrates Afirma GSC’s Ability to Significantly …” on May 23, 2018. Businesswire.com‘s article titled: “Veracyte to Present at the William Blair 38” and published on May 23, 2018 is yet another important article.

Analysts await Veracyte, Inc. (NASDAQ:VCYT) to report earnings on July, 30. They expect $-0.27 EPS, down 22.73% or $0.05 from last year’s $-0.22 per share. After $-0.27 actual EPS reported by Veracyte, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Venbio Select Advisor Llc, which manages about $380.08 million and $2.09B US Long portfolio, upped its stake in Iovance Biotherapeutics Inc by 2.83 million shares to 8.08 million shares, valued at $136.53M in 2018Q1, according to the filing. It also increased its holding in Biomarin Pharmaceutical Inc (NASDAQ:BMRN) by 1.41 million shares in the quarter, for a total of 1.71M shares, and has risen its stake in Clovis Oncology Inc (NASDAQ:CLVS).

Investors sentiment decreased to 1.04 in Q1 2018. Its down 0.19, from 1.23 in 2017Q4. It fall, as 4 investors sold VCYT shares while 24 reduced holdings. 11 funds opened positions while 18 raised stakes. 20.91 million shares or 2.49% less from 21.45 million shares in 2017Q4 were reported. Northern has invested 0% in Veracyte, Inc. (NASDAQ:VCYT). Jpmorgan Chase & reported 129,266 shares. Rhumbline Advisers, Massachusetts-based fund reported 20,462 shares. 118,767 are held by Birchview Capital L P. Wells Fargo And Company Mn accumulated 33,583 shares or 0% of the stock. Bridgeway Cap Mngmt Incorporated reported 356,800 shares or 0.02% of all its holdings. Quantum Capital holds 0.1% or 77,116 shares in its portfolio. Acuta Cap Prtn Ltd holds 3.01% in Veracyte, Inc. (NASDAQ:VCYT) or 3.32M shares. Pennsylvania-based Sei has invested 0% in Veracyte, Inc. (NASDAQ:VCYT). 4,853 are owned by Legal And General Gru Public Limited. Dekabank Deutsche Girozentrale invested 0% in Veracyte, Inc. (NASDAQ:VCYT). The New York-based Tower Rech Cap Limited Liability Company (Trc) has invested 0% in Veracyte, Inc. (NASDAQ:VCYT). Zebra Management Ltd Limited Liability Company owns 10,184 shares for 0.02% of their portfolio. 142,631 were reported by Morgan Stanley. Essex Invest Mgmt Limited Com holds 239,226 shares or 0.17% of its portfolio.

More recent Insulet Corporation (NASDAQ:PODD) news were published by: Globenewswire.com which released: “Factors of Influence in 2018, Key Indicators and Opportunity within Insulet, Everi, Ciner Resources LP, Aluminum …” on May 31, 2018. Also Businesswire.com published the news titled: “Insulin Management System Receives FDA 510(k) Clearance” on June 04, 2018. Fool.com‘s news article titled: “3 Stocks That Have Doubled and Still Have Room to Grow” with publication date: May 31, 2018 was also an interesting one.

Investors sentiment decreased to 1.08 in 2018 Q1. Its down 0.55, from 1.63 in 2017Q4. It worsened, as 25 investors sold PODD shares while 64 reduced holdings. 44 funds opened positions while 52 raised stakes. 62.11 million shares or 1.90% more from 60.95 million shares in 2017Q4 were reported. Us Bancorporation De reported 915 shares. Dimensional Fund Lp has 103,768 shares for 0% of their portfolio. Eagle Asset Incorporated invested in 0.26% or 542,254 shares. Granite Invest Prns Limited Liability Corp, California-based fund reported 13,310 shares. M&T Bancshares Corp accumulated 4,133 shares. Nelson Van Denburg And Campbell Wealth Mgmt Group Inc Limited Liability Company invested 0.01% of its portfolio in Insulet Corporation (NASDAQ:PODD). Advisory Research holds 64,205 shares. Geode Capital Mgmt Ltd Com accumulated 0.02% or 531,581 shares. Champlain Investment Partners Limited Co reported 1.04 million shares stake. San Francisco Sentry Inv Group (Ca) has 50 shares. Sg Americas Ltd reported 0% of its portfolio in Insulet Corporation (NASDAQ:PODD). Essex Invest Management Company Ltd has 0.85% invested in Insulet Corporation (NASDAQ:PODD) for 74,541 shares. 60,713 were reported by Rosenblum Silverman Sutton S F Inc Ca. Nuveen Asset Lc invested in 118,197 shares. The Manitoba – Canada-based Great West Life Assurance Can has invested 0% in Insulet Corporation (NASDAQ:PODD).

Among 21 analysts covering Insulet Corporation (NASDAQ:PODD), 15 have Buy rating, 1 Sell and 5 Hold. Therefore 71% are positive. Insulet Corporation had 60 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Friday, July 21 by Oppenheimer. Morgan Stanley maintained the shares of PODD in report on Friday, June 1 with “Equal-Weight” rating. On Thursday, October 12 the stock rating was maintained by Leerink Swann with “Buy”. The company was upgraded on Friday, April 29 by William Blair. The stock of Insulet Corporation (NASDAQ:PODD) earned “Buy” rating by Wedbush on Tuesday, October 10. Northland Capital maintained the shares of PODD in report on Friday, November 6 with “Outperform” rating. The firm has “Hold” rating by Canaccord Genuity given on Monday, September 25. Oppenheimer maintained the shares of PODD in report on Friday, August 4 with “Hold” rating. The stock has “Equal-Weight” rating by Stephens on Thursday, February 22. Cowen & Co maintained the shares of PODD in report on Wednesday, March 28 with “Buy” rating.

Next Century Growth Investors Llc, which manages about $3.86 billion and $749.49 million US Long portfolio, decreased its stake in Nmi Holdings (NASDAQ:NMIH) by 479,262 shares to 870,240 shares, valued at $14.40 million in 2018Q1, according to the filing. It also reduced its holding in Boingo Wireless Inc (NASDAQ:WIFI) by 71,300 shares in the quarter, leaving it with 718,583 shares, and cut its stake in 2U Inc (NASDAQ:TWOU).

Insulet Corporation (NASDAQ:PODD) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *